SEC 13F Intelligence

Managers / Q1 2023 · view latest →

Lion Point Capital, LP

CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200

Reported Value
$243M
Q1 2023
Positions
31
Filings on Record
31
2019–present window
Filed
May 15, 2023
original filing

Summary

Lion Point Capital, LP reported $243M in U.S.-listed holdings across 31 positions for Q1 2023.

The portfolio is heavily concentrated: SMTC alone accounts for 24.4% of reported value.

Compared with Q4 2022, the fund opened 8 new positions and exited 9.

Portfolio Metrics

Turnover
+18.2%
vs prior filed quarter
Top-10 Concentration
+66.1%
share of reported value
Largest Position
+24.4%
Semtech
New / Exited
8 / 9
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $636MQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.0BQ3 ’19: $897MQ4 ’19: $1.1BQ4 ’19Q1 ’20: $379MQ2 ’20: $412MQ3 ’20: $456MQ4 ’20: $519MQ4 ’20Q1 ’21: $550MQ2 ’21: $579MQ3 ’21: $533MQ4 ’21: $373MQ4 ’21Q1 ’22: $431MQ2 ’22: $878MQ3 ’22: $454MQ4 ’22: $703MQ4 ’22Q1 ’23: $243MQ2 ’23: $221MQ3 ’23: $224MQ4 ’23: $200MQ4 ’23Q1 ’24: $179MQ2 ’24: $55MQ3 ’24: $45MQ4 ’24: $19MQ4 ’24Q1 ’25: $16MQ2 ’25: $15MQ3 ’25: $18MQ4 ’25: $19MQ4 ’25Q1 ’26: $17Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 71.7%ETP: 25.3%Other: 3.0%
  • Common Stock · 71.7% · $174M
  • ETP · 25.3% · $61M
  • Other · 3.0% · $7M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
SMTCSEMTECH CORPNEW+2.45M2.45M+$59M$59M
MAGENTA THERAPEUTICS INCNEW+4.56M4.56M+$4M$4M
2SEVENTY BIO INCNEW+170.0K170.0K+$2M$2M
MERSANA THERAPEUTICS INCNEW+409.1K409.1K+$2M$2M
ACRSACLARIS THERAPEUTICS INCNEW+109.9K109.9K+$889,075$889,075
SATSUMA PHARMACEUTICALS INCNEW+319.7K319.7K+$223,340$223,340
HARPOON THERAPEUTICS INCNEW+169.3K169.3K+$125,980$125,980
GOOGALPHABET INCNEW+100100+$10,400$10,400

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2023

29 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1SMTCSEMTECH CORPhistory →COM24.38%$59M2.45M
2CHRDCHORD ENERGY CORPORATIONhistory →COM NEW11.72%$28M211.4K
3ARCONIC CORPORATIONCOM7.69%$19M712.4K
4MARINUS PHARMACEUTICALS INCCOM NEW7.44%$18M2.62M
5ARDXARDELYX INChistory →COM4.02%$10M2.04M
6PDC ENERGY INCCOM3.45%$8M130.4K
7DURECT CORPCOM NEW2.66%$6M1.43M
8CIVICIVITAS RESOURCES INChistory →COM NEW1.83%$4M65.0K
9MAGENTA THERAPEUTICS INCCOM1.49%$4M4.56M
10SERES THERAPEUTICS INCCOM1.39%$3M596.8K
11BURGERFI INTERNATIONAL INCCOM1.33%$3M2.75M
12CTI BIOPHARMA CORPCOM1.04%$3M601.6K
13BATLBATTALION OIL CORPhistory →COM1.03%$3M380.9K
14MIRMMIRUM PHARMACEUTICALS INCCOM0.96%$2M97.0K
152SEVENTY BIO INCCOMMON STOCK0.71%$2M170.0K
16MERSANA THERAPEUTICS INCCOM0.69%$2M409.1K
17MISTMILESTONE PHARMACEUTICALS INCOM0.69%$2M425.2K
18KINIKSA PHARMACEUTICALS LTDCOM CL A0.50%$1M113.5K
19ACRSACLARIS THERAPEUTICS INCCOM0.37%$889,075109.9K
20CYMABAY THERAPEUTICS INCCOM0.36%$866,98699.4K
21INSMINSMED INCCOM PAR $.010.35%$858,21250.3K
22ORIGIN MATERIALS INCCOM0.18%$427,000100.0K
23BLUBELLUS HEALTH INC NEWCOM NEW0.13%$324,00045.0K
24SATSUMA PHARMACEUTICALS INCCOM0.09%$223,340319.7K
25LUMOS PHARMA INCCOM0.07%$169,48951.2K
26HARPOON THERAPEUTICS INCCOM0.05%$125,980169.3K
27MSFTMICROSOFT CORPCOM0.01%$28,830100
28SDIGSTRONGHOLD DIGITAL MINING INCLASS A COM0.01%$12,40020.0K
29GOOGALPHABET INCCAP STK CL C0.00%$10,400100

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$17M35May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$19M39Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$18M27Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$15M19Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M21May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$19M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$45M25Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$55M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$179M32May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$200M30Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$224M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$221M30Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$243M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$703M32Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$454M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$878M40Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$431M35May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$373M33Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$533M38Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$579M34Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$550M30May 19, 2021RESTATEMENTchanges · EDGAR ↗
Q4 2020$519M24Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$456M24Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$412M24Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$379M25May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B26Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$897M26Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.0B24Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B24May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$636M35Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.